Explore the full directors' dealings record of LIPELLA PHARMACEUTICALS INC., a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €370k. The latest transaction was filed on 15 May 2024 (Acquisition). Among the most active insiders: Kaufman Jonathan H. Every trade is free.
4
Insider Decl.
0
Thresholds
€28,749
2 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Buys €28,749· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.